glp-1 joint pain Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions GLP-1's for Reversing Joint Damage

Sass JO, Gemperle-Britschgi C, Tarailo-Graovac M, Patel N, Walter M, Jordanova A, Alfadhel M, Baric I, Coker M, Damli-Huber A, et al

Cellular and subcellular compartmentation was yet to be elucidated

PMCID: PMC7172861

A 10 mg vial reconstituted with 3.0 mL of bacteriostatic water gives 3.33 mg/mL, and typical research doses run 0.5-1 mg daily during a loading phase before dropping to a maintenance dose once or twice weekly

Dosage for libido: 0.25 to 0.5 mg subcutaneous during a loading phase (daily for 5 to 7 days), then 0.5 mg once or twice weekly for maintenance

The peptide increases the potential for melanogenesis, and the UV light acts as the trigger to activate it